- World rank, all time
- #33,828 of 42,892
- Rank in France
- #1,871 of 2,321
- Research works
- 157 ▼ 14% vs 2013–17
- Citations
- 2.7k 17.4 per fractional work
- Top-10% rate
- 14.7% record average 16.5%
- Open access
- 24% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 8.1×. Every wedge is a field page.
- Decision Sciences 8.1×
- Immunology and Microbiology 4.0×
- Economics, Econometrics and Finance 2.7×
- Medicine 2.1×
- Energy 2.0×
- Business, Management and Accounting 1.6×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Health Professions 1.0×
- Social Sciences 0.7×
- Physics and Astronomy 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Agricultural and Biological Sciences 0.5×
- Earth and Planetary Sciences 0.5×
- Environmental Science 0.5×
- Engineering 0.5×
- Computer Science 0.3×
- Arts and Humanities 0.2×
- Mathematics 0.1×
- Psychology 0.1×
- Materials Science 0.1×
Which keywords describe research at MSD (France)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Clinical Trials, Primary Care, Inflammation, Statins, Pharmacology, Cardiovascular Disease Prevention and Digital Health.
- Medical Ethics
- Generic Drugs
- Drug Development Costs
- Arrestin
- Signal Transduction
- Glaucoma
- Crystal Structure
- Drug Discovery
- Human Papillomavirus
- Hypertension
- Management
- Cholesterol-lowering
- Inequalities
- Genetic Variants
- Pharmacology
- Global Burden
- Risk Factors
- Public Health
- Quality of Life
- Inflammation
- Epidemiology
- Clinical Trials
- Primary Care
- Cardiovascular Disease
- Statins
- Cardiovascular Disease Prevention
- Digital Health
- Healthcare Policy
- Hypercholesterolemia
- LDL Cholesterol
- Diabetes
- Cell Signaling
- Cost-effectiveness Analysis
- Health Utility Measures
- Neurodegeneration
- Pharmaceutical Industry
- Molecular Mechanisms
- Cancer Incidence
- G-Protein-Coupled Receptors
- Intraocular Pressure
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology17▲ 2.6×57 topics
- Inflammation9▲ 2.5×28 topics
- Clinical Trials7▲ 6.9×11 topics
- Quality of Life6▲ 2.9×15 topics
- Primary Care5▲ 8.1×7 topics
- Public Health5▲ 2.5×7 topics
- Cardiovascular Disease5▲ 2.9×12 topics
- Risk Factors5▲ 2.9×7 topics
- Statins5▲ 37×2 topics
- Global Burden5▲ 5.5×6 topics
- Cardiovascular Disease Prevention4▲ 36×3 topics
- Pharmacology4▲ 8.7×4 topics
- Digital Health4▲ 33×2 topics
- Genetic Variants4▲ 12×4 topics
- Healthcare Policy4▲ 36×1 topic
- Inequalities4▲ 72×1 topic
- Hypercholesterolemia4▲ 51×2 topics
- Cholesterol-lowering4▲ 50×1 topic
- LDL Cholesterol4▲ 61×1 topic
- Management4▲ 3.2×16 topics
- Diabetes4▲ 4.8×9 topics
- Hypertension4▲ 6.7×7 topics
- Cell Signaling4▲ 6.6×4 topics
- Human Papillomavirus4▲ 17×3 topics
- Cost-effectiveness Analysis3▲ 28×1 topic
- Drug Discovery3▲ 5.4×3 topics
- Health Utility Measures3▲ 28×1 topic
- Crystal Structure3▲ 7.9×2 topics
- Neurodegeneration3▲ 6.3×4 topics
- Glaucoma3▲ 12×2 topics
- Pharmaceutical Industry3▲ 45×2 topics
- Signal Transduction3▲ 7.5×2 topics
- Molecular Mechanisms3▲ 9.7×2 topics
- Arrestin3▲ 22×1 topic
- Cancer Incidence3▲ 12×3 topics
- Drug Development Costs3▲ 67×1 topic
- G-Protein-Coupled Receptors3▲ 22×1 topic
- Generic Drugs3▲ 67×1 topic
- Intraocular Pressure3▲ 16×2 topics
- Medical Ethics3▲ 9.4×2 topics
Which research topics does MSD (France) publish most on?
By volume in 2022–2025: Data Quality and Management, Cervical Cancer and HPV Research, Vaccine Coverage and Hesitancy and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Data Quality and Management Management Science and Operations Research 1 works
- 2 Cervical Cancer and HPV Research Epidemiology 1 works
- 3 Vaccine Coverage and Hesitancy Health 1 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 5 Hepatitis B Virus Studies Epidemiology 0 works
- 6 Head and Neck Cancer Studies Otorhinolaryngology 0 works
- 7 Influenza Virus Research Studies Epidemiology 0 works
- 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 9 Nosocomial Infections in ICU Critical Care and Intensive Care Medicine 0 works
- 10 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has MSD (France)'s research output changed?
Output in 2018–2022 was 14% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Courbevoie
- Fidal
- Saint-Gobain (France)
- Pôle Léonard de Vinci
- Chiesi (France)
- AstraZeneca (France)
- Ecole Supérieure d'Ingénieurs Léonard de Vinci
- Informatique Electromagnetisme Electronique Analyse Numerique (France)
- Laboratoires Expanscience
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.